This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1998;20(3-4):455-91.

doi: 10.1007/BF00838055.

Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts

R J O'Reilly¹, T N Small, E Papadopoulos, K Lucas, J Lacerda, L Koulova

Affiliations

PMID: 9870257
DOI: 10.1007/BF00838055

Review

Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts

R J O'Reilly et al. Springer Semin Immunopathol. 1998.

. 1998;20(3-4):455-91.

doi: 10.1007/BF00838055.

Authors

R J O'Reilly¹, T N Small, E Papadopoulos, K Lucas, J Lacerda, L Koulova

Affiliation

¹ Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

PMID: 9870257
DOI: 10.1007/BF00838055

No abstract available

PubMed Disclaimer

Similar articles

Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
O'Reilly RJ, Lacerda JF, Lucas KG, Rosenfield NS, Small TN, Papadopoulos EB. O'Reilly RJ, et al. Important Adv Oncol. 1996:149-66. Important Adv Oncol. 1996. PMID: 8791134 Review. No abstract available.
Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
Burns DM, Crawford DH. Burns DM, et al. Blood Rev. 2004 Sep;18(3):193-209. doi: 10.1016/j.blre.2003.12.002. Blood Rev. 2004. PMID: 15183903 Review.
EBV specific CTL: a model for immune therapy.
Rooney CM, Heslop HE, Brenner MK. Rooney CM, et al. Vox Sang. 1998;74 Suppl 2:497-8. doi: 10.1111/j.1423-0410.1998.tb05463.x. Vox Sang. 1998. PMID: 9704488 Review.
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.
Gustafsson A, Levitsky V, Zou JZ, Frisan T, Dalianis T, Ljungman P, Ringden O, Winiarski J, Ernberg I, Masucci MG. Gustafsson A, et al. Blood. 2000 Feb 1;95(3):807-14. Blood. 2000. PMID: 10648390
Preventing Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation.
Heslop HE. Heslop HE. J Immunother. 2001 Jul-Aug;24(4):283-4. doi: 10.1097/00002371-200107000-00002. J Immunother. 2001. PMID: 11565828 No abstract available.

See all similar articles

Cited by

Replicative senescence of CD8 T cells: potential effects on cancer immune surveillance and immunotherapy.
Effros RB. Effros RB. Cancer Immunol Immunother. 2004 Oct;53(10):925-33. doi: 10.1007/s00262-004-0508-x. Epub 2004 Apr 6. Cancer Immunol Immunother. 2004. PMID: 15067431 Free PMC article. Review.
Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.
Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N. Filicko-O'Hara J, et al. Biol Blood Marrow Transplant. 2009 Dec;15(12):1609-19. doi: 10.1016/j.bbmt.2009.08.020. Epub 2009 Sep 8. Biol Blood Marrow Transplant. 2009. PMID: 19744572 Free PMC article.
Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.
Nikiforow S, Bottomly K, Miller G, Münz C. Nikiforow S, et al. J Virol. 2003 Nov;77(22):12088-104. doi: 10.1128/jvi.77.22.12088-12104.2003. J Virol. 2003. PMID: 14581546 Free PMC article.
Immune deficits in allogeneic hematopoietic stem cell transplant (HSCT) recipients.
Mir MA, Battiwalla M. Mir MA, et al. Mycopathologia. 2009 Dec;168(6):271-82. doi: 10.1007/s11046-009-9181-0. Epub 2009 Jan 21. Mycopathologia. 2009. PMID: 19156534 Review.
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.
Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M, Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE. Bollard CM, et al. J Exp Med. 2004 Dec 20;200(12):1623-33. doi: 10.1084/jem.20040890. J Exp Med. 2004. PMID: 15611290 Free PMC article.

See all "Cited by" articles

References

1. Cancer Res. 1981 Nov;41(11 Pt 1):4216-21 - PubMed
1. Blood. 1995 Mar 1;85(5):1396-403 - PubMed
1. Annu Rev Immunol. 1988;6:85-113 - PubMed
1. J Exp Med. 1995 Aug 1;182(2):477-86 - PubMed
1. Blood. 1994 Aug 1;84(3):972-84 - PubMed

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information